美国儿科学会。药物委员会。儿童药物检测：美国食品药品监督管理局法规。 - Suppr | 超能文献

American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.

出版信息

Pediatrics. 1969 Mar;43(3):463-5.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.美国儿科学会。药物委员会。儿童药物检测：美国食品药品监督管理局法规。

Pediatrics. 1969 Mar;43(3):463-5.

2

American Academy of Pediatrics Committee on Drugs: Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children.美国儿科学会药物委员会：婴儿及儿童纳洛酮的剂量与给药途径：婴儿及儿童急救药物剂量补编

Pediatrics. 1990 Sep;86(3):484-5.

3

[Are children getting the right drugs?].孩子们用对药了吗？

Tidsskr Nor Laegeforen. 2005 Dec 1;125(23):3290-2.

4

Drugs for pediatric emergencies. Committee on Drugs, Committee on Drugs, 1996 to 1997, Liaison Representatives, and AAP Section Liaisons.

Pediatrics. 1998 Jan;101(1):E13.

5

American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.美国儿科学会药物委员会。“治疗孤儿药”与药品说明书。

Pediatrics. 1970 Nov;46(5):811-3.

6

Drug testing in children.

FDA Consum. 1978 Jun;12(5):11-3.

7

New pediatric dosage rules: information and testing.新的儿科用药剂量规则：信息与测试。

Pediatr Nurs. 1998 Nov-Dec;24(6):518, 613.

8

American Academy of Pediatrics Committee on Drugs: Emergency drug doses for infants and children.美国儿科学会药物委员会：婴幼儿紧急用药剂量

Pediatrics. 1988 Mar;81(3):462-5.

9

Drug development in pediatrics: problems and strategies. The point of view of the academic community.儿科药物研发：问题与策略。学术界的观点。

Pediatr Pharmacol (New York). 1980;1(1):21-4.

10

Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.已批准药物的未批准用途：医生、药品说明书与美国食品药品监督管理局：专题审查。美国儿科学会药物委员会

Pediatrics. 1996 Jul;98(1):143-5.

引用本文的文献

1

Acetaminophen causes neurodevelopmental injury in susceptible babies and children: no valid rationale for controversy.对乙酰氨基酚会对易受影响的婴幼儿造成神经发育损伤：对此存在争议毫无合理依据。

Clin Exp Pediatr. 2024 Mar;67(3):126-139. doi: 10.3345/cep.2022.01319. Epub 2023 Jun 14.